217 related articles for article (PubMed ID: 34469570)
1. The changing states of fibromyalgia in patients with axial spondyloarthritis: results from the British Society of Rheumatology Biologics Register for Ankylosing Spondylitis.
Provan SA; Dean LE; Jones GT; Macfarlane GJ
Rheumatology (Oxford); 2021 Sep; 60(9):4121-4129. PubMed ID: 34469570
[TBL] [Abstract][Full Text] [Related]
2. Influence of co-morbid fibromyalgia on disease activity measures and response to tumour necrosis factor inhibitors in axial spondyloarthritis: results from a UK national register.
Macfarlane GJ; MacDonald RIR; Pathan E; Siebert S; Gaffney K; Choy E; Packham J; Martin KR; Haywood K; Sengupta R; Atzeni F; Jones GT
Rheumatology (Oxford); 2018 Nov; 57(11):1982-1990. PubMed ID: 30053166
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of the performance of extreme patient-reported outcomes as surrogate markers for fibromyalgia in axial spondyloarthritis.
Santos-Faria D; Dougados M; Gossec L; Perrot S; Moltó A
Rheumatol Int; 2019 Jan; 39(1):141-146. PubMed ID: 30413924
[TBL] [Abstract][Full Text] [Related]
4. Evaluation of the impact of concomitant fibromyalgia on TNF alpha blockers' effectiveness in axial spondyloarthritis: results of a prospective, multicentre study.
Moltó A; Etcheto A; Gossec L; Boudersa N; Claudepierre P; Roux N; Lemeunier L; Martin A; Sparsa L; Coquerelle P; Soubrier M; Perrot S; Dougados M
Ann Rheum Dis; 2018 Apr; 77(4):533-540. PubMed ID: 29183878
[TBL] [Abstract][Full Text] [Related]
5. Fibromyalgia in Spondyloarthritis: Effect on Disease Activity Assessment in Clinical Practice.
Wach J; Letroublon MC; Coury F; Tebib JG
J Rheumatol; 2016 Nov; 43(11):2056-2063. PubMed ID: 27633820
[TBL] [Abstract][Full Text] [Related]
6. Determining factors related to poor quality of life in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS).
Macfarlane GJ; Rotariu O; Jones GT; Pathan E; Dean LE
Ann Rheum Dis; 2020 Feb; 79(2):202-208. PubMed ID: 31662321
[TBL] [Abstract][Full Text] [Related]
7. Similar biologic drug response regardless of radiographic status in axial spondyloarthritis: data from the British Society for Rheumatology Biologics Register in Ankylosing Spondylitis registry.
Michelena X; Zhao SS; Dubash S; Dean LE; Jones GT; Marzo-Ortega H
Rheumatology (Oxford); 2021 Dec; 60(12):5795-5800. PubMed ID: 33502476
[TBL] [Abstract][Full Text] [Related]
8. Co-Occurrence and Characteristics of Patients With Axial Spondyloarthritis Who Meet Criteria for Fibromyalgia: Results From a UK National Register.
Macfarlane GJ; Barnish MS; Pathan E; Martin KR; Haywood KL; Siebert S; Packham J; Atzeni F; Jones GT
Arthritis Rheumatol; 2017 Nov; 69(11):2144-2150. PubMed ID: 28622461
[TBL] [Abstract][Full Text] [Related]
9. Is fibromyalgia frequency increasing in axial spondyloarthritis? Association with fibromyalgia and biological therapies.
Sayın S; Yurdakul FG; Sivas F; Bodur H
Rheumatol Int; 2020 Nov; 40(11):1835-1841. PubMed ID: 32767083
[TBL] [Abstract][Full Text] [Related]
10. Real-world evidence of TNF inhibition in axial spondyloarthritis: can we generalise the results from clinical trials?
Jones GT; Dean LE; Pathan E; Hollick RJ; Macfarlane GJ
Ann Rheum Dis; 2020 Jul; 79(7):914-919. PubMed ID: 32327428
[TBL] [Abstract][Full Text] [Related]
11. Evaluation of the impact of fibromyalgia in disease activity and treatment effect in spondyloarthritis.
Bello N; Etcheto A; Béal C; Dougados M; Moltó A
Arthritis Res Ther; 2016 Feb; 18():42. PubMed ID: 26860612
[TBL] [Abstract][Full Text] [Related]
12. Patients with fibromyalgia rarely fulfil classification criteria for axial spondyloarthritis.
Baraliakos X; Regel A; Kiltz U; Menne HJ; Dybowski F; Igelmann M; Kalthoff L; Krause D; Saracbasi-Zender E; Schmitz-Bortz E; Braun J
Rheumatology (Oxford); 2018 Sep; 57(9):1541-1547. PubMed ID: 28968885
[TBL] [Abstract][Full Text] [Related]
13. Effects of fibromyalgia on the disease activity and treatment of patients with axial spondyloarthritis.
Gao R
J Musculoskelet Neuronal Interact; 2021 Sep; 21(3):440-446. PubMed ID: 34465685
[TBL] [Abstract][Full Text] [Related]
14. Comparison of patients with ankylosing spondylitis (AS) and non-radiographic axial spondyloarthritis (nr-axSpA) from a single rheumatology clinic in New Delhi.
Malaviya AN; Kalyani A; Rawat R; Gogia SB
Int J Rheum Dis; 2015 Sep; 18(7):736-41. PubMed ID: 26172961
[TBL] [Abstract][Full Text] [Related]
15. Impact of biological therapy on work outcomes in patients with axial spondyloarthritis: results from the British Society for Rheumatology Biologics Register (BSRBR-AS) and meta-analysis.
Shim J; Jones GT; Pathan EMI; Macfarlane GJ
Ann Rheum Dis; 2018 Nov; 77(11):1578-1584. PubMed ID: 30076155
[TBL] [Abstract][Full Text] [Related]
16. Fibromyalgia in Spondyloarthritis: Prevalence and Effect on Disease Activity and Treatment.
Olfa S; Bouden S; Sahli M; Tekaya AB; Rouached L; Rawdha T; Mahmoud I; Abdelmoula L
Curr Rheumatol Rev; 2023; 19(2):214-221. PubMed ID: 36056847
[TBL] [Abstract][Full Text] [Related]
17. Ankylosing Spondylitis versus Nonradiographic Axial Spondyloarthritis: Comparison of Tumor Necrosis Factor Inhibitor Effectiveness and Effect of HLA-B27 Status. An Observational Cohort Study from the Nationwide DANBIO Registry.
Glintborg B; Sørensen IJ; Østergaard M; Dreyer L; Mohamoud AA; Krogh NS; Hendricks O; Andersen LS; Raun JL; Kowalski MR; Danielsen L; Pelck R; Nordin H; Pedersen JK; Kraus DG; Christensen SR; Hansen IM; Esbesen J; Schlemmer A; Loft AG; Al Chaer N; Salomonsen L; Hetland ML
J Rheumatol; 2017 Jan; 44(1):59-69. PubMed ID: 27909080
[TBL] [Abstract][Full Text] [Related]
18. Presence of Fibromyalgia Syndrome and Its Relationship with Clinical Parameters in Patients with Axial Spondyloarthritis.
Rencber N; Saglam G; Huner B; Kuru O
Pain Physician; 2019 Nov; 22(6):E579-E585. PubMed ID: 31775411
[TBL] [Abstract][Full Text] [Related]
19. Different drug survival of first line tumour necrosis factor inhibitors in radiographic and non-radiographic axial spondyloarthritis: a multicentre retrospective survey.
Lopalco G; Venerito V; Cantarini L; Emmi G; Salaffi F; Di Carlo M; Tafuri S; Gentileschi S; Di Scala G; Nivuori M; Cacciapaglia F; Galeazzi M; Lapadula G; Iannone F
Clin Exp Rheumatol; 2019; 37(5):762-767. PubMed ID: 31025925
[TBL] [Abstract][Full Text] [Related]
20. Comorbidity and response to TNF inhibitors in axial spondyloarthritis: longitudinal analysis of the BSRBR-AS.
Zhao SS; Jones GT; Macfarlane GJ; Hughes DM; Moots RJ; Goodson NJ
Rheumatology (Oxford); 2021 Sep; 60(9):4158-4165. PubMed ID: 33369676
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
